You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,158,653


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,158,653
Title:Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline
Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNF.alpha. in a mammal.
Inventor(s): Muller; George W. (Bridgewater, NJ), Stirling; David I. (Branchburg, NJ), Chen; Roger Shen-Chu (Edison, NJ)
Assignee: Celgene Corporation (Summit, NJ)
Application Number:11/401,862
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,158,653

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with exclusive rights to their innovations. United States Patent 8,158,653, like any other patent, has a specific scope and set of claims that define its boundaries and protections. Here, we will delve into the details of this patent, exploring its claims, the patent landscape, and relevant legal and practical considerations.

What is United States Patent 8,158,653?

To analyze the patent, it is essential to identify its subject matter. However, the specific details of Patent 8,158,653 are not provided in the sources. Generally, patents are categorized by their technological field, and each patent includes a detailed description of the invention, drawings, and claims.

Patent Claims

Patent claims are the heart of any patent, as they define the scope of the invention and the rights granted to the patent holder. Here are some key points about patent claims:

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim[3].

Claim Construction

The interpretation of patent claims is critical in determining the scope of protection. Claim construction involves analyzing the language of the claims, the specification, and the prosecution history to understand what the claims cover[3].

Patent Scope

The scope of a patent is determined by its claims and is influenced by several factors:

Patent Specification

The specification provides a detailed description of the invention, including drawings and examples. It helps in understanding the context and limitations of the claims[3].

Prosecution History

The history of how the patent was prosecuted, including any amendments or arguments made during the application process, can affect the interpretation of the claims[3].

Patent Landscape

The patent landscape refers to the broader context of related patents and intellectual property in the same technological field.

Prior Art

Prior art includes all existing knowledge and inventions in the public domain before the filing date of the patent. It is crucial in determining the novelty and non-obviousness of the invention[4].

Patent Families

A patent family includes all related patent applications and patents filed in different jurisdictions. Analyzing patent families can provide insights into the global protection strategy of the patent holder[4].

Legal Considerations

Several legal aspects are important when analyzing a patent:

Infringement

Patent infringement occurs when someone makes, uses, sells, or imports a product that falls within the scope of the patent claims without permission from the patent holder. The case of Celgene vs. Hetero illustrates how companies can dispute infringement claims, especially in the pharmaceutical sector[1].

Validity Challenges

Patents can be challenged for validity based on grounds such as lack of novelty, obviousness, or insufficient disclosure. Hetero’s Paragraph IV Certifications, for example, challenged the validity of several Celgene patents[1].

Practical Considerations

Search and Analysis Tools

The USPTO provides various tools for searching and analyzing patents, including the Patent Public Search tool and the Global Dossier. These tools help in identifying prior art, understanding patent families, and analyzing claim dependencies[4].

Economic Impact

Patents have significant economic implications. The Patent Claims Research Dataset by the USPTO provides insights into patent scope and claims, which can be useful for economic research and policy-making[3].

Case Studies and Examples

Celgene vs. Hetero

The dispute between Celgene and Hetero over the validity and infringement of Celgene’s patents highlights the complexities involved in patent litigation. Hetero’s Paragraph IV Certifications and Celgene’s subsequent legal actions demonstrate the importance of thorough claim analysis and legal strategy[1].

Expert Insights

Legal Experts

Legal experts such as those involved in the ACUS study on a small claims patent court emphasize the need for clear and enforceable patent claims. They also highlight the challenges and costs associated with patent litigation, which can be a significant burden for small inventors and companies[5].

Statistics and Trends

Patent Filings

The number of patent filings and grants can indicate trends in innovation and technological advancement. The USPTO’s datasets provide detailed statistics on patent filings and grants over the years, which can be useful in understanding the broader patent landscape[3].

Key Takeaways

  • Patent Claims: The claims define the scope of protection and are crucial in determining infringement and validity.
  • Patent Scope: The scope is influenced by the specification, prosecution history, and prior art.
  • Legal Considerations: Infringement and validity challenges are critical legal aspects to consider.
  • Practical Tools: The USPTO provides several tools for searching and analyzing patents.
  • Economic Impact: Patents have significant economic implications and are subject to detailed economic research.

FAQs

Q: What are the main components of a patent? A: The main components include the specification, drawings, and claims.

Q: How are patent claims constructed? A: Claim construction involves analyzing the language of the claims, the specification, and the prosecution history.

Q: What is prior art, and why is it important? A: Prior art includes all existing knowledge and inventions in the public domain before the filing date of the patent. It is crucial in determining the novelty and non-obviousness of the invention.

Q: What tools does the USPTO provide for patent searching? A: The USPTO provides tools such as the Patent Public Search tool, Global Dossier, and the Publication Site for Issued and Published Sequences (PSIPS).

Q: Why is the economic impact of patents significant? A: Patents have significant economic implications as they influence innovation, competition, and investment in research and development.

Sources

  1. Charles M. Lizza, William C. Baton, Sarah A. Sullivan, One Riverfront Plaza, et al. Case 2:20-cv-02601-ES-MAH Document 1 Filed 03/10/20.
  2. U.S. Patent and Trademark Office. U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. U.S. Patent and Trademark Office. Patent Claims Research Dataset - USPTO.
  4. U.S. Patent and Trademark Office. Search for patents - USPTO.
  5. Administrative Conference of the United States. U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,158,653

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,158,653

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0925294 ⤷  Subscribe 91359 Luxembourg ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe CA 2007 00054 Denmark ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe 07C0056 France ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe SPC033/2007 Ireland ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe SPC/GB07/047 United Kingdom ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe SZ 56/2007 Austria ⤷  Subscribe
European Patent Office 0925294 ⤷  Subscribe C00925294/01 Switzerland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.